ID
32551
Description
A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00655668
Link
https://clinicaltrials.gov/show/NCT00655668
Keywords
Versions (1)
- 11/6/18 11/6/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
November 6, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility T-cell Non-Hodgkin's Lymphoma NCT00655668
Eligibility T-cell Non-Hodgkin's Lymphoma NCT00655668
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Similar models
Eligibility T-cell Non-Hodgkin's Lymphoma NCT00655668
- StudyEvent: Eligibility
C0449560 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
C0854826 (UMLS CUI [2])
C0854827 (UMLS CUI [3])
C1265611 (UMLS CUI [1,2])